252 related articles for article (PubMed ID: 6237807)
1. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
2. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
3. Effect of pacing-induced myocardial ischemia on platelet activation and fibrin formation in the coronary circulation.
Nichols AB; Gold KD; Marcella JJ; Cannon PJ; Owen J
J Am Coll Cardiol; 1987 Jul; 10(1):40-5. PubMed ID: 2955018
[TBL] [Abstract][Full Text] [Related]
4. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
5. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
[TBL] [Abstract][Full Text] [Related]
6. Exercise-induced myocardial ischemia in patients with coronary artery disease: lack of evidence for platelet activation or fibrin formation in peripheral venous blood.
Marcella JJ; Nichols AB; Johnson LL; Owen J; Reison DS; Kaplan KL; Cannon PJ
J Am Coll Cardiol; 1983 May; 1(5):1185-93. PubMed ID: 6339591
[TBL] [Abstract][Full Text] [Related]
7. Objective assessment of heparin requirements for hemodialysis in humans.
Ireland H; Lane DA; Curtis JR
J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
[TBL] [Abstract][Full Text] [Related]
8. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.
Watkins MW; Luetmer PA; Schneider DJ; Witmer WT; Vaitkus PT; Sobel BE
Cathet Cardiovasc Diagn; 1998 Jul; 44(3):257-64. PubMed ID: 9676792
[TBL] [Abstract][Full Text] [Related]
9. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
10. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation caused by cardiac catheter blood collection, and its prevention.
Mant MJ; Kappagoda CT; Taylor RF; Quinlan JE
Thromb Res; 1984 Jan; 33(2):177-87. PubMed ID: 6230755
[TBL] [Abstract][Full Text] [Related]
12. Studies of thromboxane B2, platelet factor 4, and fibrinopeptide A in bleeding-time blood of patients deficient in von Willebrand factor, platelet glycoproteins Ib and IIb-IIIa, and storage granules.
Weiss HJ; Lages B
Blood; 1993 Jul; 82(2):481-90. PubMed ID: 8329704
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
Kaplan KL; Nossel HL; Drillings M; Lesznik G
Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
[TBL] [Abstract][Full Text] [Related]
14. Fibrin formation and platelet activation in patients with myocardial infarction and normal coronary arteries.
Rapold HJ; Haeberli A; Kuemmerli H; Weiss M; Baur HR; Straub WP
Eur Heart J; 1989 Apr; 10(4):323-33. PubMed ID: 2524385
[TBL] [Abstract][Full Text] [Related]
15. Platelet-released proteins as molecular markers for the activation process.
Walz DA
Semin Thromb Hemost; 1984 Oct; 10(4):270-9. PubMed ID: 6240116
[TBL] [Abstract][Full Text] [Related]
16. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
17. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
[TBL] [Abstract][Full Text] [Related]
18. Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease?
Gallino A; Häberli A; Straub PW; Steinbrunn W; Turina M; Rothlin ME
Eur Heart J; 1987 Jul; 8(7):734-7. PubMed ID: 2958280
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation.
Bugiardini R; Chierchia S; Crea F; Gallino A; Wild S; Roskovec A; Lenzi S; Maseri A
Am Heart J; 1984 Aug; 108(2):255-60. PubMed ID: 6205577
[TBL] [Abstract][Full Text] [Related]
20. Neonatal and maternal platelets: activation at time of birth.
Suarez CR; Gonzalez J; Menendez C; Fareed J; Fresco R; Walenga J
Am J Hematol; 1988 Sep; 29(1):18-21. PubMed ID: 2972197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
